stockportfolio.pro
Stocks / BKD vs TLX
BKD vs TLX
Brookdale Senior Living Inc. and Telix Pharmaceuticals Limited side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Brookdale Senior Living Inc. (BKD) | Telix Pharmaceuticals Limited (TLX) | |
|---|---|---|
| Market cap | $3.2B | $3.2B |
| Revenue (latest FY) | $3.19B | $803.79M |
| Net income (latest FY) | $-262.69M | $-7.13M |
| Revenue growth (5y CAGR) | -2.0% | 94.7% |
| Net margin | -8.2% | -0.9% |
| Return on equity | 587.0% | -1.7% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 2 |
| Positive free cash flow | Yes | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BKD — free Open TLX — freeFrequently asked questions
Which is bigger, BKD or TLX?
Telix Pharmaceuticals Limited is larger by market capitalization — $3.2B versus $3.2B.
Which grows faster, BKD or TLX?
Over the last five fiscal years, Telix Pharmaceuticals Limited grew revenue faster — 94.7%/yr versus -2.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.